Indications and uses
■ temporarily relieves runny nose and alleviates sneezing, itching of the nose or throat, and itchy, watery eyes due to hay fever or other upper respiratory allergies.
■ temporarily relieves runny nose and alleviates sneezing, itching of the nose or throat, and itchy, watery eyes due to hay fever or other upper respiratory allergies.
■ mL= milliliter ■ use enclosed 15 mL dose cup and keep with product ■ children 6 to under 12 years: 30 mL (2 dose cups) every 6 to 8 hours, not to exceed 4 doses in 24 hours, or as directed by a doctor ■ children under 6 years of age: consult a doctor.
CHILDRENS PEDIACLEAR 8
NDC: 58809-770-08
(in each 15 mL)
Pyrilamine Maleate 12.5 mg
Antihistamine
■ temporarily relieves runny nose and alleviates sneezing, itching of the nose or throat, and itchy, watery eyes due to hay fever or other upper respiratory allergies.
■ a breathing problem such as emphysema or chronic bronchitis
■ glaucoma
taking sedatives or tranquilizers
■ marked drowsiness may occur
■ sedatives and tranquilizers may increase drowsiness
■ excitability may occur, especially in children
new symptoms occur
In case of overdose, get medical help or contact a Poison Control Center right away.
■ mL= milliliter
■ use enclosed 15 mL dose cup and keep with product
■ children 6 to under 12 years: 30 mL (2 dose cups) every 6 to 8 hours, not to exceed 4 doses in 24 hours, or as directed by a doctor
■ children under 6 years of age: consult a doctor.
■ each 15 mL contains: Sodium 6 mg
■ read all product information before using
■ this packaging is child-resistant
■ store at room temperature 20-30°C (68-86°F)
citric acid anhydrous, glycerin, propylene glycol, purified water, sodium benzoate, sodium citrate, sorbitol, sucralose
Call 1-888-535-0305 9 a.m. - 5 p.m. CST.
NDC 58809-770-08
Children’s
PediaClear
8 Eight
8 fl oz (237 mL)
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 2178281 | PediaClear 12.5 MG in 15 mL Oral Solution | PSN | 9 |
| 2178279 | pyrilamine maleate 12.5 MG in 15 mL Oral Solution | PSN | 9 |
| 2178281 | pyrilamine maleate 0.833 MG/ML Oral Solution [Pediaclear] | SBD | 9 |
| 2178279 | pyrilamine maleate 0.833 MG/ML Oral Solution | SCD | 9 |
| 2178281 | Pediaclear 0.833 MG/ML Oral Solution | SY | 9 |
| 2178281 | Pediaclear 12.5 MG per 15 mL Oral Solution | SY | 9 |
| 2178279 | pyrilamine maleate 12.5 MG per 15 mL Oral Solution | SY | 9 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| d5e51f11-ad28-caa4-4b49-4143974782ad | Product name | 1 | 20150831 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 58809-770-08 | Childrens PediaClear 8 | 237 mL in 1 BOTTLE | LIQUID | 237 | 9 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 58809-770-08 | ML - Milliliter | 58809-770 | aa10cc27-d748-4478-83a6-231f5b1849f2 | 1 | 2019-08-06 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 58809-770 | 58809-770-08 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ANHYDROUS CITRIC ACID | XF417D3PSL | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| WATER | 059QF0KO0R | IACT |
| SODIUM BENZOATE | OJ245FE5EU | IACT |
| SODIUM CITRATE | 1Q73Q2JULR | IACT |
| SORBITOL | 506T60A25R | IACT |
| SUCRALOSE | 96K6UQ3ZD4 | IACT |
| PYRILAMINE MALEATE | R35D29L3ZA | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Childrens PediaClear 8 | PYRILAMINE MALEATE | GM Pharmaceuticals, INC | 8e524967-d01c-4c93-9198-c42f15fe3fe0 | 2025-10-03 | Warnings | 58809-770-08 58809-770 58809077008 404600cf-672a-ccf7-e063-6394a90a1b51 8e524967-d01c-4c93-9198-c42f15fe3fe0 |
Adverse event summaries are temporarily unavailable. Other product information remains available.